SuRo Capital Corp. 6.00% Notes due 2026
SSSSL scores 29.8 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.
Net penalties of -41.8 points significantly impact the ranking. Without these adjustments, SSSSL would rank considerably higher.
These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.
| Stock | Score | P/E | Rev Growth | Margin | Mkt Cap |
|---|---|---|---|---|---|
| SSSSL | 29.8 | 3.3 | -29.2% | 913.5% | $629M |
| CME | 86.4 | 27.2 | 9.9% | 57.5% | $114.0B |
| FHB | 84.9 | 11.8 | 3.2% | 24.2% | $3.1B |
| ACT | 84.5 | 8.9 | 2.4% | 54.6% | $6.1B |
| CINF | 84.2 | 10.7 | 11.4% | 18.9% | $25.4B |
| SEIC | 82.2 | 14.0 | 10.7% | 27.3% | $9.9B |
| TROW | 79.9 | 10.1 | 3.1% | 28.5% | $20.5B |
| QQQX | 79.7 | 10.4 | 48.6% | 257.3% | $1.4B |
| IBOC | 78.2 | 10.6 | 7.5% | 40.1% | $4.2B |
| HWC | 77.8 | 12.2 | -1.5% | 24.1% | $5.6B |
| FFIN | 77.5 | 18.8 | 11.7% | 30.7% | $4.7B |
| TRMK | 77.1 | 11.9 | 34.8% | 19.3% | $2.6B |
| NMIH | 77.1 | 7.7 | 8.4% | 55.1% | $3.0B |
| EWBC | 76.7 | 12.7 | 4.6% | 28.3% | $15.3B |
| WSFS | 76.3 | 12.8 | -3.1% | 21.1% | $3.5B |
| MCHB | 76.1 | N/A | 123.7% | 23.2% | $3.1B |
| Sector Average | 47.5 | 26.8 | 13.4% | -2.8% | — |
SuRo Capital (Nasdaq: SSSS, formerly known as GSV Capital) is a publicly-traded fund that seeks to invest in high-growth, venture-backed private companies. The firm primarily seeks to invest in social mobile, sustainability, cloud computing, big data, marketplaces, and education sectors. It also seeks to create a portfolio of high-growth emerging private companies through a repeatable and disciplined investment approach, as well as to provide investors with access to such companies through its publicly traded common stock. SuRo Capital was established in 2011 and is headquartered in San Francisco, California.
Stock is losing momentum near highs. The 200-day SMA is flattening or beginning to turn. Historically, this stage precedes distribution.
Stage 3 distribution — institutional selling pressure is building. Avoid new positions. If already holding, consider reducing and tightening stops below SMA50.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $6M | $167,304 | $499,094 | $1M |
| Gross Profit | $10M | $65M | $2M | $4M |
| Operating Income | $9M | $62M | $-806,715 | $44,527 |
| Net Income | $7M | $62M | $-806,715 | $44,527 |
| EPS (Diluted) | $0.26 | $2.23 | $-0.03 | $0.00 |
| Gross Margin | 177.8% | 38816.8% | 419.6% | 315.4% |
| Operating Margin | 153.7% | 37254.4% | -161.6% | 3.6% |
| Net Margin | 131.1% | 37254.4% | -161.6% | 3.6% |
This stock has limited trading volume and/or float. Institutional investors may face difficulty entering or exiting positions without significant price impact. A post-hoc penalty has been applied to the composite score (this is not a backtested model factor — it is a practical tradability overlay).
This stock has traded in a compressed range for 4 of the last 4 years (3-year range: 13.1%). Range-bound stocks may indicate limited upside potential. A -5pt penalty has been applied.
| Year | Low | High | Range | Status |
|---|---|---|---|---|
| 2022 | $22.07 | $25.95 | 16.2% | Narrow |
| 2023 | $22.28 | $25.00 | 11.5% | Narrow |
| 2024 | $23.40 | $25.00 | 6.6% | Narrow |
| 2025 | $24.20 | $25.40 | 4.8% | Narrow |
Growth estimates have been dampened based on technical and fundamental signals. This is a post-hoc adjustment to prevent overly optimistic projections for stocks showing declining momentum or deteriorating fundamentals.
Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.